Skip to main content

Table 3 Forest plot of the endpoints according to treatment regimen and DM/CKD status

From: Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

  1. Adjusted to age, sex, body mass index (BMI), clinical presentation (ACS versus stable CAD), stroke, peripheral vascular disease (PVD), chronic obstructive pulmonary disease (COPD), previous PCI, hypercholesterolemia, hypertension, current smoking status, complex PCI, ACEI or ARB, beta-blockade, statin, Paris thrombotic risk score, and Paris bleeding risk score
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840